Evidence map›Paper›PMID 35621231›Full record

ArticleCancer medicine2022

Global, regional, and national burden of cancers attributable to tobacco smoking in 204 countries and territories, 1990-2019.

Saeid Safiri, Seyed Aria Nejadghaderi, Morteza Abdollahi, Kristin Carson-Chahhoud, Jay S Kaufman, Nicola Luigi Bragazzi, Maziar Moradi-Lakeh, Mohammad Ali Mansournia, Mark J M Sullman, Amir Almasi-Hashiani and 3 more

Abstract read
In one paragraph

Article in Cancer medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Saeid SafiriAging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0001-7986-9072
Seyed Aria NejadghaderiAging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran.ORCID 0000-0002-8692-9720
Morteza AbdollahiSocial Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-0310-2021
Kristin Carson-ChahhoudAustralian Centre for Precision Health, University of South Australia, Adelaide, South Australia, Australia.ORCID 0000-0001-9966-9289
Jay S KaufmanDepartment of Epidemiology, Biostatistics and Occupational Health, Faculty of Medicine, McGill University, Quebec, Canada.ORCID 0000-0003-1606-401X
Nicola Luigi BragazziCentre for Disease Modelling, York University, Toronto, Ontario, Canada.ORCID 0000-0001-8409-868X
Maziar Moradi-LakehPreventive Medicine and Public Health Research Center, Iran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-7381-5305
Mohammad Ali MansourniaDepartment of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-3343-2718
Mark J M SullmanDepartment of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus.ORCID 0000-0001-7920-6818
Amir Almasi-HashianiDepartment of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran.ORCID 0000-0003-4434-561X
Ali TaghizadiehTuberculosis and Lung Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Gary S CollinsCentre for Statistics in Medicine, NDORMS, Botnar Research Centre, University of Oxford, Oxford, UK.ORCID 0000-0002-2772-2316
Ali-Asghar KolahiSocial Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-0178-3732

Funding

Cancer Research UK 27294
6 · The paper itself

Abstract

backgroundCancers are leading causes of mortality and morbidity, with smoking being recognized as a significant risk factor for many types of cancer. We aimed to report the cancer burden attributable to tobacco smoking by sex, age, socio-demographic index (SDI), and cancer type in 204 countries and territories from 1990 to 2019.

methodsThe burden of cancers attributable to smoking was reported between 1990 and 2019, based upon the Comparative Risk Assessment approach used in the Global Burden of Disease (GBD) study 2019.

resultsGlobally, in 2019 there were an estimated 2.5 million cancer-related deaths (95% UI: 2.3 to 2.7) and 56.4 million DALYs (51.3 to 61.7) attributable to smoking. The global age-standardized death and DALY rates of cancers attributable to smoking per 100,000 decreased by 23.0% (-29.5 to -15.8) and 28.6% (-35.1 to -21.5), respectively, over the period 1990-2019. Central Europe (50.4 [44.4 to 57.6]) and Western Sub-Saharan Africa (6.7 [5.7 to 8.0]) had the highest and lowest age-standardized death rates, respectively, for cancers attributable to smoking. In 2019, the age-standardized DALY rate of cancers attributable to smoking was highest in Greenland (2224.0 [1804.5 to 2678.8]) and lowest in Ethiopia (72.2 [51.2 to 98.0]). Also in 2019, the global number of DALYs was highest in the 65-69 age group and there was a positive association between SDI and the age-standardized DALY rate.

conclusionsThe results of this study clearly illustrate that renewed efforts are required to increase utilization of evidence-based smoking cessation support in order to reduce the burden of smoking-related diseases.

Indexed as

Global Burden of DiseaseNeoplasmsEthiopiaGlobal HealthHumansQuality-Adjusted Life YearsRisk FactorsTobacco Smokingcancerdeathdisability-adjusted life yearglobal burden of diseasesmoking

Identifiers

PMID35621231
PMCPMC9249976

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.